Alessandra Latini

Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

John Gregson, Michele W. Tang, Nicaise Ndembi et al. · The Lancet Infectious Diseases · 2016 · 275 citations · Full text

Public Health, Pharmacology, Pharmacotherapy +17

Analysis of the ORFK1 hypervariable regions reveal distinct HHV-8 clustering in Kaposi’s sarcoma and non-Kaposi’s cases

Paola Cordiali‐Fei, Elisabetta Trento, Marta Giovanetti et al. · Journal of Experimental & Clinical Cancer Research · 2015 · 159 citations · Full text

Life Sciences, Infectious Diseases, Pathology +13

Therapeutic Immunization with HIV-1 Tat Reduces Immune Activation and Loss of Regulatory T-Cells and Improves Immune Function in Subjects on HAART

Barbara Ensoli, Stefania Bellino, Antonella Tripiciano et al. · PLoS ONE · 2010 · 95 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Reliability and Clinical Relevance of the HIV-1 Drug Resistance Test in Patients With Low Viremia Levels

Maria Mercedes Santoro, Lavinia Fabeni, Daniele Armenia et al. · Clinical Infectious Diseases · 2014 · 87 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M)

Simona Di Giambenedetto, Massimiliano Fabbiani, Eugenia Quirós-Roldán et al. · Journal of Antimicrobial Chemotherapy · 2016 · 75 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16